See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← PSYL page
XStocksXray
Market X-Ray report · 23 October 2026

Pakistan Synthetics Ltd (PSYL)

Karachi Stock Exchange · Pakistan · prices in PKR · close of 23 Oct 2026

Key indicators

Last closePKR 180.33
52-week range53.01 – 226.00
Return, 1 month / 3 months+19.5% / +26.3%
Return, 1 year / 3 years+226.3% / +668.3%
TrendUptrend
RSI (14)48
Volatility (1 year)65.6%
Worst drawdown (1 year)-31.2%
Average daily value traded1.98M PKR
Dividend yield–

Market X-Ray price-based

72/ 100 · High confidence · ahead of 89% of stocks on this exchange
Trend90
Momentum96
Stability (higher is calmer)52
Liquidity33
Income–

Fair value limited data

Average of 3 modelsPKR 139.74Model uncertainty High
Versus priceOvervalued−23% to fair value

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

8.9565.23122178234Fair value $1402021-102023-092024-092025-092026-10

Summary

Pakistan Synthetics Ltd (PSYL) trades on the Karachi Stock Exchange in Pakistan. It last closed at PKR 180.33 on 23 October 2026.

Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 56 of 494 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 226.3% and over the last three months it rose 26.3%. Returns are price returns, dividends not included.

Our limited-data fair value is PKR 139.74 (Overvalued, −22.5% to fair value). It averages 3 models built from the earnings and sales this exchange publishes. Their weights were fitted to a professional consensus-style valuation of Pakistani stocks and checked on stocks left out of the fit, but no analyst forecasts are used, so read it as a rough range.

stocksxray.com · page 1
XStocksXray
Pakistan Synthetics Ltd (PSYL)

The five lenses in numbers each metric is ranked against the other stocks on Karachi Stock Exchange

Lens and metricValueScoreReading
Trend90 · StrongTrading above its long-term averages and near its highs.
Above 200-day average65.2%
From 52-week high-18.8%
Momentum96 · StrongRising faster than most stocks on this exchange.
3-month return26.3%
6-month return148.7%
12-month return, skipping the last month173.1%
Stability (higher is calmer)52 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)65.6%
Worst drawdown, 1 year (smaller is calmer)-31.2%
Liquidity33 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded1.98M PKR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−16.8%
1 month+19.5%
3 months+26.3%
6 months+148.7%
1 year+226.3%
3 years+668.3%
5 years+475.5%

Signals

50-day / 200-day average158.07 / 109.15
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)17.82

Technical summary

DailyBullish9 bullish · 2 neutral · 5 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 0 neutral · 1 bearish

Recent dividends

Ex-dividend dateAmount per share
13 Oct 2021PKR 2.7500

Fair value models PSX income statement only (no balance sheet or cash flow): only earnings, sales and dividend models can be built

P/E multiplePKR 139.44
P/S multiplePKR 135.14
P/E on average earningsPKR 144.62

How to read this report

Every number comes from end-of-day prices and dividends and the earnings and sales this exchange publishes. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Karachi Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026